Extracorporeal photopheresis combined with pentostatin in the conditioning regimen for canine hematopoietic cell transplantation does not prevent GVHD

[1]  S. Forman,et al.  Hematopoietic Cell Transplantation , 2015 .

[2]  R. Storb,et al.  Extracorporeal Photopheresis in Addition to Pentostatin in Conditioning for Canine Hematopoietic Cell Transplantation: Role in Engraftment , 2010, Bone Marrow Transplantation.

[3]  E. Ostrander,et al.  A class of highly polymorphic tetranucleotide repeats for canine genetic mapping , 1996, Mammalian Genome.

[4]  A. Ibatici,et al.  Extracorporeal photopheresis for the treatment of steroid refractory acute GVHD , 2008, Bone Marrow Transplantation.

[5]  P. Rubegni,et al.  Extracorporeal photopheresis affects co‐stimulatory molecule expression and interleukin‐10 production by dendritic cells in graft‐versus‐host disease patients , 2008, Clinical and experimental immunology.

[6]  A. Balduzzi,et al.  Extracorporeal Photochemotherapy Is Accompanied by Increasing Levels of Circulating CD4+CD25+GITR+Foxp3+CD62L+ Functional Regulatory T-Cells in Patients With Graft-Versus-Host Disease , 2007, Transplantation.

[7]  E. Shpall,et al.  Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD. , 2006, Blood.

[8]  F. Foss.  The role of purine analogues in low-intensity regimens with allogeneic hematopoietic stem cell transplantation. , 2006, Seminars in hematology.

[9]  K. Matsuo,et al.  Impact of human leucocyte antigen mismatch on graft‐versus‐host disease and graft failure after reduced intensity conditioning allogeneic haematopoietic stem cell transplantation from related donors , 2005, British journal of haematology.

[10]  G. Gorgun,et al.  A novel reduced intensity regimen for allogeneic hematopoietic stem cell transplantation associated with a reduced incidence of graft-versus-host disease , 2004, Bone Marrow Transplantation.

[11]  F. Appelbaum,et al.  Thomas' hematopoietic cell transplantation , 2003 .

[12]  F. Foss,et al.  Reduced-intensity transplantation for patients with myelodysplastic syndrome achieves durable remission with less graft-versus-host disease. , 2003, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[13]  J. Armitage,et al.  Lymphodepleting effects and safety of pentostatin for nonmyeloablative allogeneic stem-cell transplantation. , 2003, Transplantation.

[14]  G. Gorgun,et al.  Persistence of host dendritic cells after transplantation is associated with graft-versus-host disease. , 2003, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[15]  G. Gorgun,et al.  Immunologic mechanisms of extracorporeal photochemotherapy in chronic graft-versus-host disease. , 2002, Blood.

[16]  G. Gorgun,et al.  Extracorporeal photopheresis in chronic graft-versus-host disease , 2002, Bone Marrow Transplantation.

[17]  G. Gorgun,et al.  Immunomodulatory effects of extracorporeal photochemotherapy in patients with extensive chronic graft-versus-host disease. , 2001, Blood.

[18]  A. Oliven,et al.  Extracorporeal photopheresis: a review. , 2001, Blood reviews.

[19]  J. Bladon,et al.  Extracorporeal photopheresis induces apoptosis in the lymphocytes of cutaneous T‐cell lymphoma and graft‐versus‐host disease patients , 1999, British journal of haematology.

[20]  P. Rubegni,et al.  Photopheresis for recurrent acute rejection in cardiac transplantation. , 1999, Transplantation proceedings.

[21]  H. Hönigsmann,et al.  Successful use of extracorporeal photochemotherapy in the treatment of severe acute and chronic graft-versus-host disease. , 1998, Blood.

[22]  R. Storb,et al.  DLA-DRB1 and DLA-DQB1 histocompatibility typing by PCR-SSCP and sequencing. , 1998, Tissue antigens.

[23]  F. Locatelli,et al.  Photopheresis in paediatric patients with drug‐resistant chronic graft‐versus‐host disease , 1997, British journal of haematology.

[24]  P. Henslee-Downey,et al.  Use of partially mismatched related donors extends access to allogeneic marrow transplant. , 1997, Blood.

[25]  H. Deeg,et al.  Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation. , 1997, Blood.

[26]  Y. Shyr,et al.  Long-term follow-up of patients with cutaneous T-cell lymphoma treated with extracorporeal photochemotherapy. , 1996, Journal of the American Academy of Dermatology.

[27]  R. Storb,et al.  Molecular analysis of DLA-DRBB1 polymorphism. , 1996, Tissue antigens.

[28]  E. Ostrander,et al.  Histocompatibility testing of dog families with highly polymorphic microsatellite markers. , 1996, Transplantation.

[29]  F. Gasparro,et al.  Apoptosis induction of ultraviolet light A and photochemotherapy in cutaneous T-cell Lymphoma: relevance to mechanism of therapeutic action. , 1996, The Journal of investigative dermatology.

[30]  C Haanen,et al.  A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. , 1995, Journal of immunological methods.

[31]  H. Kerl,et al.  Photopheresis for renal allograft rejection , 1995, The Lancet.

[32]  Henslee-Downey Pj.  Mismatched bone marrow transplantation. , 1995 .

[33]  P. Henslee-Downey.  Mismatched bone marrow transplantation , 1995, Current opinion in oncology.

[34]  W. Siegert,et al.  Successful treatment of chronic graft-versus-host disease with extracorporeal photopheresis. , 1994, Bone marrow transplantation.

[35]  E. Bryant,et al.  USE OF (CA)n POLYMORPHISMS TO DETERMINE THE ORIGIN OF BLOOD CELLS AFTER ALLOGENEIC CANINE MARROW GRAFTING , 1994, Transplantation.

[36]  B. Sandmaier,et al.  'Resistance' to unrelated, DLA-nonidentical canine marrow grafts is unrestricted by the major histocompatibility complex. , 1994, Experimental hematology.

[37]  C. Jacobsen,et al.  Reactivities of 20 anti-human monoclonal antibodies with leucocytes from ten different animal species. , 1993, Veterinary immunology and immunopathology.

[38]  D. Danilenko,et al.  Monoclonal antibodies specific for canine CD4 and CD8 define functional T-lymphocyte subsets and high-density expression of CD4 by canine neutrophils. , 1992, Tissue antigens.

[39]  I. Bernstein,et al.  Biochemical characterization of a unique canine myeloid antigen. , 1991, Leukemia.

[40]  R. Storb,et al.  An antibody that facilitates hematopoietic engraftment recognizes CD44. , 1990, Blood.

[41]  W. Ladiges.  4 – Experimental Techniques Used to Study the Immune System of Dogs and Other Large Animals , 1989 .

[42]  H. Deeg,et al.  Graft failure in patients receiving T cell-depleted HLA-identical allogeneic marrow transplants. , 1988, Bone marrow transplantation.

[43]  H. Deeg,et al.  FAILURE OF ALLOGENEIC CANINE MARROW GRAFTS AFTER TOTAL‐BODY IRRADIATION: ALLOGENEIC “RESISTANCE” VERSUS TRANSFUSION‐INDUCED SENSITIZATION , 1986, Transplantation.

[44]  H. Deeg,et al.  Morphologic and phenotypic analysis of canine natural killer cells: evidence for T-cell lineage. , 1985, Cellular immunology.

[45]  I. Bernstein,et al.  Influence of antibody isotype on passive serotherapy of lymphoma. , 1985, Journal of immunology.

[46]  H. Deeg,et al.  The canine major histocompatibility complex. Population study of DLA-D alleles using a panel of homozygous typing cells. , 2008, Tissue antigens.

[47]  J. Heavner.  Methods of animal experimentation , 1965 .